rawfin.tv
Mabwell Receives Brazilian GMP Certification for Denosumab Injections
RegulationstocksAI Generated

Mabwell Receives Brazilian GMP Certification for Denosumab Injections

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Mabwell, a biopharmaceutical company, has successfully passed a Brazilian GMP inspection for its Denosumab injections, securing its second PIC/S GMP certification. This regulatory milestone enhances Mabwell's market access and product credibility.

BiopharmaRegulatory approvalGMPBrazilPharmaceuticals

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks